Results 1 to 10 of about 50,232 (267)

Contemporary NSTEMI management: the role of the hospitalist. [PDF]

Hospital Practice, 2019
Non-ST-segment elevation myocardial infarction (NSTEMI) is defined as elevated cardiac biomarkers of necrosis in the absence of persistent ST-segment elevation in the setting of anginal symptoms or other acute event.
Amin, Alpesh, Cohen, Marc, Deitelzweig, Steven, DiLascia, Christopher, Fanikos, John, Kaatz, Scott, Pollack, Charles V, Slattery, David, Tuder, Regan, Wang, Tracy   +9 more
core   +6 more sources

Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology

European Heart Journal Quality of Care & Clinical Outcomes, 2023
Background The majority of NSTEMI burden resides outside high-income countries (HICs). We describe presentation, care, and outcomes of NSTEMI by country income classification.
Ramesh Nadarajah, Peter F Ludman, Yolande Appelman   +2 more
exaly   +2 more sources

Oxidants and antioxidants in myocardial infarction (MI): Investigation of ischemia modified albumin, malondialdehyde, superoxide dismutase and catalase in individuals diagnosed with ST elevated myocardial infarction (STEMI) and non-STEMI (NSTEMI) [PDF]

Journal of Medical Biochemistry, 2021
Background: Coronary ischemia can lead to myocardial damage and necrosis. The pathogenesis of cardiovascular diseases often includes increased oxidative stress and decreased antioxidant defense.
Aladağ Nesim, Asoğlu Ramazan, Ozdemir Mahmut, Asoğlu Emin, Derin Atabey Rukiye, Demir Canan, Demir Halit   +6 more
doaj   +2 more sources

Differences in mortality and causes of death between STEMI and NSTEMI in the early and late phases after acute myocardial infarction

PLoS ONE, 2021
Background The detailed causes of death in non–ST-segment–elevation myocardial infarction (NSTEMI) have not been adequately evaluated compared to those in ST-segment elevation myocardial infarction (STEMI).
Yasuaki Takeji, Hiroki Shiomi, Takeshi Morimoto, Ko Yamamoto, Yukiko Matsumura-Nakano, Kazuya Nagao, Ryoji Taniguchi, Kyohei Yamaji, Tomohisa Tada, Eri Toda Kato, Yusuke Yoshikawa, Yuki Obayashi, Satoru Suwa, Moriaki Inoko, Natsuhiko Ehara, Toshihiro Tamura, Tomoya Onodera, Hiroki Watanabe, Mamoru Toyofuku, Kenji Nakatsuma, Hiroki Sakamoto, Kenji Ando, Yutaka Furukawa, Yukihito Sato, Yoshihisa Nakagawa, Kazushige Kadota, Takeshi Kimura, the CREDO-Kyoto AMI Registry Wave-2 Investigators   +27 more
doaj   +3 more sources

Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry

European Heart Journal Quality of Care & Clinical Outcomes, 2022
AIMS The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) Non-ST-segment elevation myocardial infarction (NSTEMI) Registry aims to identify international patterns in NSTEMI management in clinical practice and outcomes ...
Ramesh Nadarajah, Peter F Ludman, Yolande Appelman   +2 more
exaly   +2 more sources

Invasive versus non-invasive management of older patients with non-ST elevation myocardial infarction (SENIOR-NSTEMI): a cohort study based on routine clinical data

Lancet, The, 2020
Summary Background Previous trials suggest lower long-term risk of mortality after invasive rather than non-invasive management of patients with non-ST elevation myocardial infarction (NSTEMI), but the trials excluded very elderly patients.
Amit Kaura, Adam Trickey, Sam Abbott
exaly   +2 more sources

Managing NSTEMI in older patients [PDF]

Lancet, The, 2021
Alberto Cordero,, Fesc, Moisés Rodríguez-Mañero, Vicente Bertomeu-González   +2 more
exaly   +7 more sources

The Effects of Allopurinol on Levels of Cardiac Troponin Following Non-ST Elevation Myocardial Infarction: A Pilot Randomized Clinical Trial [PDF]

Pharmaceutical Sciences, 2021
Background: Given the potential anti-ischemic effects of allopurinol, we aimed to assess whether allopurinol administration may reduce myocardial injury following non-ST elevation myocardial infarction (NSTEMI). Methods: A randomized clinical trial (RCT)
Sajad Khiali, Parvin Sarbakhsh, Sina Mashayekhi, Elham Mohamadrezapour, Samaneh Dousti, Taher Entezari-Maleki   +5 more
doaj   +1 more source

Acute myocardial infarction at a district hospital in KwaZulu-Natal – Management and outcomes

South African Family Practice, 2022
Background: Acute myocardial infarction (AMI) following ischaemic heart disease (IHD) is associated with increased morbidity and mortality. The condition remains a management challenge in resource-constrained environments.
Zakariya Badat, Selvandran Rangiah
doaj   +1 more source

Poor prognosis of total culprit artery occlusion in patients presenting with NSTEMI

European Heart Journal, 2023
The prognosis of STEMI and NSTEMI patients stratified according to invasive angiographic findings of an occluded culprit coronary, i.e., occlusion myocardial infarction (OMI), remains unclear.
R. Herman, S. Smith, H. Meyers, D. Bertolone, A. Leone, K. Bermpeis, M. Viscusi, M. Martonak, J. Bahyl, A. Demolder, L. Perl, W. Wojakowski, J. Bartunek, E. Barbato   +13 more
semanticscholar   +1 more source